Skip to content

Pilot Study of Empathic Assessment and Coping Support for Dyspnea in Patients with Advanced Lung Cancer

A Single-Arm Before-and-After Pilot Study of Nurse-Led Empathic Assessment and Individualized Coping Support for Dyspnea in Patients with Advanced Lung Cancer - Pilot Study of Dyspnea Support for Patients with Advanced Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061943
Enrollment
10
Registered
2026-06-17
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Nurse led non pharmacological intervention consisting of empathic assessment of dyspnea experiences, assessment of psychosocial factors, breathing techniques, self management support, and individualiz

Sponsors

Gifu University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with advanced lung cancer (stage IIIb/IV or recurrent disease) and receiving anticancer drug therapy; patients with subjective dyspnea and a dyspnea score of 2 or higher on the breathlessness item of the questionnaire on ease of daily living at admission; patients scheduled for an outpatient visit approximately 2 weeks after discharge; age 20 years or older; able to provide written informed consent; and able to communicate in Japanese and participate in face to face interviews.

Exclusion criteria

Exclusion criteria: Patients judged to have difficulty expressing their intentions due to cognitive impairment or disturbance of consciousness. Patients judged to have marked difficulty participating in the study because of psychiatric disorders or acute psychological symptoms. Patients with severe comorbidities that are expected to cause acute exacerbation of dyspnea during the study period (e.g., acute exacerbation of interstitial lung disease or severe infection). Patients considered inappropriate for study participation by the attending physician or the principal investigator.

Design outcomes

Primary

MeasureTime frame
Change in Self-Efficacy Scale for Advanced Cancer score

Countries

Japan

Contacts

Public ContactAyumi Sugimura

Tokai National Higher Education and Research System Gifu University School of Nursing

sugimura.ayumi.e4@f.gifu-u.ac.jp0582933226

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026